Disclosure Of Entity's Operating Segments [Text Block]

BerGenBio - Filing #2615544

Concept As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Disclosure of entity's operating segments [text block]
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue
774,000 NOK
601,000 NOK
Tax expense (income)
0 NOK
0 NOK
Profit (loss) before tax
309,364,000 NOK
257,029,000 NOK
Profit (loss)
309,364,000 NOK
309,364,000 NOK
257,029,000 NOK
257,029,000 NOK
Assets
450,236,000 NOK
738,200,000 NOK
Liabilities
65,810,000 NOK
67,971,000 NOK
Cash flows from (used in) operating activities
303,340,000 NOK
234,290,000 NOK
Cash flows from (used in) investing activities
3,130,000 NOK
3,548,000 NOK
Cash flows from (used in) financing activities
15,995,000 NOK
699,507,000 NOK
Disclosure of products and services [text block]
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]
Disclosure of major customers [abstract]
Disclosure of major customers [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.